247; Importance: 148; Text: 7140 14 15 16 17 18 19 2 20 ABSTRACT 21 Neuraminidase inhibitors (NAIs) are antiviral agents recommended worldwide to treat or 22 prevent influenza virus infections in humans. Mapping of functional resistance to 23 currently licensed NAIs has been limited to human influenza viruses with only sporadic 24 reports investigating avian influenza viruses (AIV). However past pandemics as well as 25 the increasing number of humans infected with AIV have shown the importance of 26 having information about avian NAs that could cross the species barrier. In this study 27
INTRODUCTION
Wild aquatic birds are the major reservoir of avian influenza virus (AIV) worldwide. AIVs 60 frequently transmit from these reservoir species to other bird populations such as 61 domestic poultry, from where they can cross additional species barriers and jump into 62 mammalian hosts such as humans. An increase of human infections caused by different 63 AIV subtypes in the recent years [1] [2] [3] [4] [5] [6] together with the evidence pointing at the avian 64 origins of past influenza pandemics [7, 8] places AIV strains as a significant concern to 65 public health. 66 The emergence of drug resistance is an inherent risk associated with therapeutic use of IAV isolates including H1N1, H3N2 and H7N9, and shown to confer resistance to at 155 least one NAI drug [12, 13, 21, [33] [34] [35] [36] [37] [38] . One substitution occurs at the actual catalytic 156 residue (R292K) critical for the enzymatic function of NA, whereas three other changes detectable haemagglutinating properties on chicken red blood cells. This virus was 177 however able to generate plaques on an MDCK cell layer. 178 The impact of three remaining mutations on the enzymatic activity of NA varied among 179 virus subtypes. The E119V mutation (red bars) significantly reduced the NA activity of 180 H5N6, H5N8, H5N2, H7N9 and H6N1 (Figure 2A , B, C, D & F, respectively), but not of 181 H4N6 ( Figure 2E ). The substitution H274Y (green bars) led to a significant drop in NA 182 activity for H7N9 and H5N2, and an increase for H5N8, whereas other subtypes 183 remained unaffected. The N294S amino acid change (magenta bars) significantly 184 impaired NA activity of all subtypes except H6N1. 185 To determine the relative NA activity of H5N8_R292K we normalised the raw values to 186 PFU (Plaque Forming Units) and compared the ratios for H5N8 subtype 187 (Supplementary Figure 1B) . The NA activity/PFU of H5N8_R292K mutant was 188 significantly reduced (~6000 times) compared to wt NA. E119V and N294S led to a 189 significant reduction whereas H274Y substitution resulted in a significant increase of 190 sialidase activity of recombinant viruses ( Supplementary Figure 1) . These results 191 corresponded to the NA activity profile with values normalised to HAU. ( Figure 2B ). .
192
Susceptibility profile of tested viruses to licenced neuraminidase inhibitors 193 (NAIs). 194 We next determined the susceptibility of the generated viruses to three neuraminidase Table 2 ). The outcomes of the assay were interpreted using the WHO 199 recommendations for classification of antiviral drug resistance: normal inhibition (NI; 200 <10-fold increase in IC 50 compared to a corresponding drug-sensitive strain), reduced 201 inhibition (RI; IC 50 increase between 10 -100-fold), highly reduced inhibition (HRI; 202 >100-fold increase). 203 The graphic representation of NAIs IC 50 shows that the E119V and H274Y mutations 204 introduced in the NA of H5N6 background resulted in RI by OSE (75-and 13-fold 205 increase, respectively; Figure 3A ), and that N294S led to RI by ZAN (18-fold increase; 206 Figure 3B ). All three substituted NA variants remained susceptible to PER ( Figure 3C ). 207 The IC 50 values for H5N6_R292K were determined using plaque reduction assay 208 (PRA), as the fluorescent signal generated using MUNANA did not reach the 209 recommended threshold for signal-to-background ratio. No reduction in plaque size was 210 observed for H5N6_R292K even in the presence of the highest OSE concentration (10 211 μM; Figure 4A and D), whereas the same concentration of ZAN or PER reduced the 212 H5N6_R292K plaque size by approximately 40% compared to wt ( Figure 4B and E; C 213 and F, respectively). Based on the generated dose response curves of the PRA we 214 concluded that H5N6_R292K showed HRI for all three NAIs: it remained unresponsive 215 to OSE treatment and showed a 2008-fold IC 50 increase over wt for ZAN and 17200-fold 216 IC 50 increase for PER (Table 2 and Figure 4) .
217
The E119V substitution tested in the H5N8 background conferred resistance to all three 218 inhibitors, with HRI for ZAN and PER (255-fold and 130-fold increase, respectively; 219 Figure 3E -F) and RI for OSE (30-fold increase; Figure 3D ). The viruses bearing H274Y 220 and N294S showed IC 50 increase for both, OSE (202-fold and 79-fold, respectively; 221 Figure 3D ) and PER (244-fold and 15-fold; Figure 3F ), but not ZAN ( Figure 3E ). The 222 drug resistance profile for H5N8_R292K could neither be determined by MUNANA 223 assay because of insufficient NA activity, nor PRA, due to small size of the plaques 224 formed by wt H5N8, making visualisation of the control virus unreliable.
225
The R292K catalytic site substitution in the H5N2 backbone led to HRI by OSE 226 (1268-fold increase; Figure 3G ) and RI by ZAN and PER (26-and 100-fold increase, 227 respectively; Figure 3H -I). Two other mutations induced an increase in IC 50 for a single 228 drug each: E119V for OSE (48-fold; Figure 3G ) and N294S for ZAN (14-fold; Figure   229 3H). The H5N2_H274Y remained sensitive to all three antivirals tested ( Figure 3G -I).
230
As determined by MUNANA assay three of the mutations introduced in H6N1 231 background caused resistance to OSE (E119V 18-fold, H274Y 262-fold and N294S 232 55-fold increase) and PER (E119V 99-fold, H274Y 575-fold, and N294S 25-fold 233 increase), whereas only one substitution reduced the susceptibility to ZAN (E119V, 234 597-fold increase in IC 50 ). Drug resistance profile for H6N1_R292K was determined 235 using PRA due to very low NA activity in MUNANA assay and gave an IC 50 value 2264- One amino acid change in H7N9 virus induced high resistance to PER (R292K, 242 3374-fold increase), whereas two substitutions -R292K and N294S -conferred RI by 243 ZAN (81-and 12-fold increase, respectively). H7N9_E119V was shown to be resistant 244 to OSE (63-fold increase). Although the IC 50 for H7N9_R292K could not be determined 245 from OSE dose-response curve of MUNANA assay, the virus was classified as highly 246 resistant to this drug as no reduction in fluorescent signal was detected even at the 247 highest (10 μM) OSE concentration.
248
Reduced inhibition to OSE was found when E119V and N294S substitutions were 249 placed in H4N6 background (32-and 37-fold increase in IC 50 , respectively).
250
H4N6_R292K virus exhibited 52-fold increase in IC 50 for ZAN (RI), 2366-fold increase 251 for PER (HRI), and high resistance level to OSE as no reduction in fluorescence signal 252 was observed in the presence of increasing drug concentrations.
253
In summary, we screened 30 avian viruses and identified 15 viruses resistant to OSE 254 (of which 5 showed HRI), 9 to ZAN (3 were HRI) and 11 to PER (7 were HRI) ( Table 2) .
255

In vitro replication kinetics of NAI-resistant H5N6 and H6N1 viruses in cKC.
256
To understand whether introduced mutations, besides compromising NA activity, also 257 affect virus ability to support efficient infection, we used primary chicken kidney cells 258 (cKC) and assessed the replicative capacity of two AIV subtypes bearing NAI 259 resistance-associated markers. The viruses were selected based on the following 260 criteria: 1) the mutations introduced in NA gene conferred functional resistance to at 261 least one NAI, as determined in NAI inhibition assay ( changes in HA of H6N1 were found, two H5N6 mutants acquired single amino acid 326 substitutions in their HA following one passage in eggs: Y98F (H3 numbering) in the NA 327 R292K mutant and A189T in N294S NA mutant virus ( Figure 6A ). Both mutations have 328 previously been shown to alter receptor binding affinity in human strains [19, 39] . We 329 used partly desialylated cRBCs to explore the impact on receptor binding avidity in 330 H5N6 of the Y98F and A189T mutations in HA ( Figure 6B ). Both HA mutants showed 331 significantly reduced receptor binding avidity as compared to wt: the Y98F HA mutation 332 present in the R292K NA virus was reduced by 94% and the A189T HA mutation 333 present in the N294S was reduced by 95% (both p < 0.01). Surprisingly, the NA E119V 334 mutant, despite lack of compensatory mutations in HA also exhibited decreased 335 receptor binding avidity by ~55% (p < 0.05). We screened in total 30 recombinant viruses, including wt NA, for their resistance to 375 NAIs (Table 2 ). PR8 was used as a reference strain in each experiment to monitor the 376 inter-assay variability, and its NAI susceptibility profile was consistent with the one (Table 2) 406 or plaque size in MDCK cells (Figure 4 A, D, G and J). 407 We also compared the drug resistance profiles of avian N1 and N2 tested here with the Figure 1 ) which revealed the same 430 trend in NA activity and drug sensitivity to the HA normalised data set in this case. 431 Changes in NA that alter the sialidase activity often result in concurrent changes in HA 432 or NA that alter the sialic acid binding avidity and thus haemagglutination potential of 433 red blood cells. 434 We investigated the effect that NAI resistance mediated by the selected mutations had 435 on viral fitness of two subtypes H5N6 and H6N1 in chicken primary kidney cells (cKCs).
436
Despite functionally compromised NAs, the selected NAI-resistant mutants of both 437 H5N6 and H6N1 replicated to comparable or even higher titres than the corresponding 438 wt NAI sensitive virus ( Figure 5A ). However to confirm that the growth patterns we observed in cKC were not a result of 450 NA-independent virus spread, we also performed the growth curves in ovo ( Figure C-E) . 451 We found no significant differences in virus growth between wt H5N6 and NAI-resistant . Indeed we can show that both mutations also significantly reduced 468 the receptor binding avidity of the H5N6 viruses when compared to wt ( Figure 6B ). The 469 rapid appearance of these HA mutations as consensus sequence changes following 470 rescue and one passage in eggs, of the NA mutant viruses suggests that in the absence 471 of these mutations viable virus carrying the prescribed NA mutations (R292K or N294S) 472 in the H5N6 context would not have been present. In contrast we did not identify any 473 compensatory signatures in HA of H5N6 E119V although its NA activity as well as the 474 receptor binding avidity were significantly reduced. Acquisition of concurrent mutations 475 in HA is the most common mechanism for compensating NA deficiency however this this could be responsible for the reduced RBC avidity of the E119V mutant. 485 We have shown that the resistance pattern of avian influenza viruses is very diverse 486 and depends on the strain as well as the antiviral used, and there is no universal 487 signature conferring resistance to all NAI drugs in all genetic backgrounds. We have 488 also demonstrated that despite significantly compromised NA activities drug-resistant 489 viruses were able to re-balance the sialidase deficiency by acquiring concurrent (Table 1) .
530
HAs originating from HPAIV retained the multi-basic cleavage site in the HA coding at -80°C and titrated by plaque assay on MDCK cells.
598
Receptor binding avidity assay. 599 To investigate possible differences in receptor binding avidity of recombinant viruses we 600 performed HA assay with partially de-sialylated cRBCs as described elsewhere Statistical analyses. 626 Statistical analyses were performed in Graph Pad Prism software (GraphPad Prism 
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